Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02080572
Other study ID # AG033947-03A1
Secondary ID 2R44AG033947-03A
Status Completed
Phase N/A
First received March 4, 2014
Last updated February 4, 2015
Start date February 2014

Study information

Verified date February 2015
Source Great Lakes NeuroTechnologies Inc.
Contact n/a
Is FDA regulated No
Health authority United States: Food and Drug Administration
Study type Observational

Clinical Trial Summary

Changes in deep brain stimulation (DBS) settings can have a delayed effect on gait function, which makes it impractical to optimize DBS for gait parameters in the clinic. Wearable movement sensors could be used to assess gait impairment in the patient's home hours after treatment adjustments are made in the clinic. This study aims to quantitatively evaluate the effects of turning off deep brain stimulation on lower extremity and gait function over three hours. This study will provide vital information about our patient worn system's ability to detect changes in lower impairment over time, which could be used to assist with DBS tuning for the lower extremities and gait in the future.


Recruitment information / eligibility

Status Completed
Enrollment 22
Est. completion date
Est. primary completion date December 2014
Accepts healthy volunteers No
Gender Both
Age group 21 Years and older
Eligibility Inclusion Criteria:

- Diagnosis of idiopathic Parkinson's disease

- Age > 21

- Underwent DBS surgery targeting the subthalamic nucleus (STN)

- Bilateral or midline involvement when "off" DBS/medication state

- Clinical history of gait impairment or freezing of gait

Exclusion Criteria:

- "Parkinson's plus" syndrome, secondary, or atypical Parkinson's disease

- Underwent DBS surgery targeting the ventral intermediate (VIM)

- Unable to walk independent of a wheelchair (use of assistive devices, like a cane, is okay for this study)

- Dementia (determined by a neuropsychological assessment).

Study Design

Observational Model: Case-Only, Time Perspective: Cross-Sectional


Related Conditions & MeSH terms


Locations

Country Name City State
United States University of Cincinnati Cincinnati Ohio
United States University Hospitals of Case Western Cleveland Ohio

Sponsors (4)

Lead Sponsor Collaborator
Great Lakes NeuroTechnologies Inc. National Institute on Aging (NIA), University Hospital Case Medical Center, University of Cincinnati

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Effect of DBS cessation on motor function over time Motor function evaluations (movement speed and magnitude) will be collected at various time points after DBS cessation. The effects over time will be examined. All data will be collected within a single session not to exceed 4 hours. All data will be analyzed within one month of study completion. No